Effector phenotype and immunologic specificity of T cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
1965 • 3,333 citations
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
1986 • 1,787 citations
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
1983 • 1,307 citations
Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity
1983 • 1,040 citations
Cancer Research: Some Forward Steps
1965 • 733 citations
A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin
1976 • 478 citations
Accurate Identification of Experimental Pulmonary Metastases2
1966 • 418 citations
STUDIES ON THE IMMUNOLOGICAL RESPONSE TO FOREIGN TUMOR TRANSPLANTS IN THE MOUSE
1955 • 317 citations
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
1981 • 317 citations
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
1985 • 295 citations
Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
1987 • 292 citations
In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2
1987 • 250 citations
Passive Immunotherapy of Cancer in Animals and Man
1977 • 245 citations
Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.
1987 • 211 citations
TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES
1964 • 149 citations
The Choice of Animal Tumors for Experimental Studies of Cancer Therapy
1978 • 143 citations
Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.
1980 • 141 citations
Adoptive immunotherapy of newly induced murine sarcomas.
1985 • 137 citations
Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.
1981 • 130 citations
Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
1987 • 129 citations
Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
1984 • 100 citations
Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
1988 • 99 citations
Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
1986 • 95 citations
Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors
1972 • 95 citations
In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.
1986 • 89 citations
Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
1989 • 89 citations
Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
1988 • 86 citations
Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
1984 • 80 citations
Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
1988 • 64 citations
In Vivo Elimination by Specific Effector Cells of an Established Syngeneic Rat Moloney Virus-Induced Sarcoma
1979 • 62 citations
Regression of Established Intradermal Tumors and Lymph Node Metastases in Guinea Pigs After Systemic Transfer of Immune Lymphoid Cells
1977 • 60 citations
Immunological approaches to cancer therapeutics
1983 • 55 citations
Tumor neutralization, immunotherapy, and chemoimmmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro.
1977 • 46 citations
The questionable immunogenicity of certain neoplasms
1977 • 45 citations
Immunological approaches to cancer therapeutics
1982 • 33 citations
Tumor Neutralization, Immunotherapy, and Chemoimmunotherapy of a Friend Leukemia with Cells Secondarily Sensitized in vitro
1977 • 32 citations
In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
1987 • 32 citations
Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
1987 • 31 citations
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
1988 • 25 citations